Phase 2 Multiple Sclerosis, Relapsing-Remitting Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco74 enrolled1 locationNCT05359653
Recruiting
Phase 2
TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Strasbourg, France40 enrolled5 locationsNCT03910738
Recruiting
Phase 2
RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial
Multiple Sclerosis, Relapsing-Remitting
RemeGen Co., Ltd.30 enrolled1 locationNCT04625153